The Section of Antitrust Law of the American Bar Association is
pleased to present the Pharmaceutical Industry Antitrust Handbook,
Second Edition. This handbook is intended to provide comprehensive
guidance about the analysis of the most important antitrust questions faced
today by pharmaceutical companies and participants in related health care
industries, and is designed to update the original Handbook, published in
The Handbook provides an overview of the pharmaceutical industry,
including the market participants, FDA regulatory structure, and
background on private litigation and government enforcement. It then
addresses the substantive antitrust issues presented by mergers and
acquisition, joint ventures, various forms of potentially anticompetitive
conduct, and distribution. Finally, it discusses the kinds of economic data
that are integral to antitrust analysis for this industry.
The Section of Antitrust Law is grateful to Second Edition editors
Jacqueline Grise and Richard Coe, who applied their substantial
experience regarding these markets to this edition and who devoted
extensive time and effort to its preparation. We believe this Second
Edition provides a valuable and unique resource to both the antitrust and
pharmaceutical communities.
March 2018 Jonathan M. Jacobson
Chair, Section of Antitrust Law
American Bar Association

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT